missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ HPi1 Monoclonal Antibody (HIC0-4F9)

Description
HPi1 Monoclonal Antibody for IHC (F), ICC/IF, Flow
Stem cells offer a therapeutic promise for many diseases. In the case of diabetes, stem cells offer the promise that beta cells may be generated ex vivo for the possible transplantation and cure of Type I diabetes (Couri CE, et al.). For this to happen, stem cells will need to be isolated and expanded, they will need to be differentiated toward the beta cell lineage, and the differentiated cell progeny used for transplantation may need to be isolated from complex cell mixtures following differentiation. Appropriate markers targeting cell surface molecules on developing and mature pancreatic cells will be required for such research.
Specifications
Specifications
| Antigen | HPi1 |
| Applications | Flow Cytometry, Immunohistochemistry (Frozen), Immunocytochemistry |
| Classification | Monoclonal |
| Clone | HIC0-4F9 |
| Concentration | Conc. Not Determined |
| Conjugate | Unconjugated |
| Formulation | Tissue culture supernatant with 0.09% sodium azide |
| Gene Alias | Pancreas Marker HPi1 |
| Host Species | Mouse |
| Immunogen | Human pancreatic enriched islet cells containing low levels of exocrine and ductal cells. |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?